Powerful CJC 1295 With Dac Growth Hormone Peptide 2mg For Lean Muscles

Descripción:

CJC-1295 is an injectable peptide used to increase GH production. This peptide is a growth hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.

The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. En general, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.

The other principal GHRH product is Mod GRF 1-29, which in most instances I recommend over CJC-1295. The products differ in their duration of action. Mod GRF has an approximately-ideal short duration of action allowing pulsatile dosing, whereas CJC-1295 has an extended duration of action which prevents such dosing.

It’s important to avoid confusing CJC-1295 with “CJC-1295 w/o DAC.” The latter is not CJC-1295, but rather is misnamed Mod GRF. When a peptide doesn’t have DAC, it’s not CJC-1295.

CJC 1295 is sometimes marketed as “CJC-1295 with DAC.” This simply is CJC-1295.

specification

Aplicaciones:

Those looking for anti-aging benefits, improved physique and sense of well being.

Administration of single doses of CJC-1295 resulted in a 2- to 10-fold increase in mean serum GH levels in all dosing groups, which was dose incremental and persisted for up to 6 dias. Similarly, a dose-related increase in mean serum IGF-I levels was observed at all dose levels, ranging from 1.5- to 3-fold and persisting for up to 14 dias. Administration of ascending multiple doses of CJC-1295 resulted in elevated levels of GH, similar to those observed after a single dose.

En contraste, elevations in IGF-I levels showed a progressive effect over time, particularly in subjects receiving CJC-1295 every 7 d. Results of the multiple-dose study suggest both a cumulative pharmacokinetic effect [es decir. persistence of elevated predose levels of IGF-I in all dosing groups except group 1 (es decir. two injections of 30 µg/kg)] and a pituitary priming effect (es decir.progressively greater C_máximo and progressively shorter T_máximo after serial dosing). The data indicate that a minimum dosing interval of 7 d appears reasonable. The most appropriate dosing interval will be determined based on actual efficacy and safety data from longer-term therapeutic studies in patients with various clinical conditions.

No serious adverse reactions were reported in either study. The most frequently reported adverse events in subjects receivingCJC-1295 were injection site reactions, consisting of transient pain, swelling, and induration that were sometimes accompanied by local urticaria. Injection site reactions tended to be more severe and/or prolonged at higher dose levels. Headache, diarrhea, and flushing were also observed, with occasional transient and mild hypotension, but occurred primarily at higher doses.

Adverse effects complicate the use of GH in the treatment of HIV-associated metabolic conditions such as wasting and lipodystrophy. Although increases in the daily dose of GH from 1 a 6 mg are associated with dose-responsive benefits, doses of 2–3 mg/d or greater are associated with edema, arthralgias, and glucose intolerance. These side effects can become dose limiting. In the current studies, none of the subjects experienced these adverse effects. Future clinical trials on this disorder will confirm whether the use of GHRH rather than GH will circumvent these problems, as has been suggested in recent publications.

In summary, a single sc administration of CJC-1295 produced sustained elevations of serum GH and IGF-I levels in normal subjects for nearly 2 wk. Weekly or biweekly administration of CJC-1295 resulted in stimulation of GH and IGF-I secretion for at least 7 d. Both single and multiple doses of CJC-1295 over 2 wk were safe and generally well tolerated, particularly at doses of 30 y 60 µg/kg. Future studies are indicated to evaluate the clinical utility of treatment with CJC-1295 in patients with intact GH secretory capacity.

Now for any GH releaser’s benefits to reach full potential, somatostatin has to be controlled because it will inhibit gh release. Using an agent known as an Acetylcholinesterase inhibitor will allow acetyl chlorine levels to rise by preventing acethylcholineesterase from overriding acetylcholine; acetylcholine will inhibit somastostatin production. An example of a natural acetylcholinieestarase would be Huzperine A. A recommended dosage for HuzperineA would be around 50mcg. Now as mentioned before a more potent pharm grade somastostatin inhibitor would be Ipamorelin.

Logically speaking it would make PERFECT sense to combine CJC-1295 with Ipamorelin since you get the increase in GH from CJC and the increase of GH pulse frequencies with a reduction in somatostatin from the Ipamorelin. This leads to a maximal GH release effect, thus allowing for maximum anabolism from optimized GH without desensitization.

Recommended Dosage

When you order this peptide, you’ll usually receive vials which come with 2mg or 5 milligrams of powdered CJC-1295. This powder will need to be reconstituted via bacteriostatic water or sterile water. Instructions for reconstitution should be included with your peptide – be sure to follow them precisely. Insulin syringes are used to measure and administrate this peptide.

CJC-1295 can be used subcutaneous (Subq) or intramuscular (IM). My personal opinion is it does not matter, at the end both are absorbed equally.CJC1295 no DAC/ Mod GRF 1-29 standard dose is 100mcg at a time or 1mcg per kg bodyweight.

CJC1295 with DAC weekly dose is around 2mg, again it will depend on your bodyweigh.

This GHRH peptide until mixed with bacteriostatic or sterile water is best stored at fridge or room temperature (outside of sunlight) and may stored this way for up to 90 dias. Those who want to keep their supplies fresh for longer periods of time may freeze lyophilized CJC-1295 powder and keep it until expiry date. Once peptide is reconstituted, it should be stored in a fridge at all times.

———————————————————————————————————————————————————————————————————————————————————————-

Contacta ahora